A zebrafish melanophore model of amyloidβ toxicity
Date
2010
Authors
Newman, M.
Wilson, L.
Camp-Dotlic, E.
Verdile, G.
Martins, R.
Lardelli, M.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Zebrafish, 2010; 7(2):155-159
Statement of Responsibility
Morgan Newman, Lachlan Wilson, Esther Camp, Giuseppe Verdile, Ralph Martins and Michael Lardelli
Conference Name
Abstract
Reliable animal models are required to facilitate the understanding of neurodegenerative pathways in Alzheimer's disease. Animal models can also be employed to search for disease-modifying drugs. The embryos and larvae of zebrafish are particularly advantageous for this purpose. For Alzheimer's disease, drugs that can ameliorate amyloidβ (Aβ) toxicity have therapeutic and/or prophylactic potential. We attempted to generate a zebrafish model of Aβ toxicity that would be viable and fertile but have a highly visible pigmentation phenotype in larvae. The larvae could then be arrayed in microtiter plates to screen compound libraries for drugs acting to reduce Aβ toxicity. We used the promoter of the zebrafish mitfa (nacre) gene to drive expression of the pathological 42 amino acid species of human Aβ, Aβ42, specifically in the highly visible melanophores (melanocytes) of transgenic zebrafish. However, the transgenic fish only showed an aberrant pigment phenotype in adults at the advanced age of 16 months. Nevertheless, our results show that alteration of zebrafish pigment pattern may be useful for analysis of toxic peptide action.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright © 2010, Mary Ann Liebert, Inc. publishers